title: Characterization of an etoposide-resistant human ovarian cancer cell line.
abstract: Etoposide (VP-16) is one of the most important anticancer agents available and is used in many chemotherapeutic regimens. To characterize resistance to this drug, we established a VP-16-resistant human ovarian cancer cell line, SKOV3/VP, by continuous stepwise exposure of SKOV3 cells to VP-16. The degree of resistance to VP-16 of SKOV3/VP was about 25 times that of the parent cell line (SKOV3), and SKOV3/VP showed cross-resistance to teniposide, adriamycin, CPT-11, and vincristine. The accumulation of [3H]-VP-16 observed in SKOV3/VP cells was about half that seen in SKOV3 cells, and the accumulation of Adriamycin by this resistant cell line was also lower than that of its parent. Overexpression of neither the multidrug resistance gene mdr-1, the multidrug-resistance-associated protein (mrp) gene, nor P-glycoprotein was detected using reverse transcriptase-polymerase chain reaction analysis and flow cytometry with MRK-16, a monoclonal antibody against P-glycoprotein. The topoisomerase II activity of nuclear extracts from SKOV3/VP cells was lower than that from the parental cells, as was the amount of DNA topoisomerase II, demonstrated by immunoblotting. These results suggest that the mechanism responsible for the multidrug resistance of this cell line may be attributable to changes on its DNA topoisomerase II and to its reduced accumulation of the drugs as compared with the parental line SKOV3.
authors.affiliation: Pharmacology Division, National Cancer Center Research Institute, Tokyo, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Kubota
authors.forename: K
authors.initials: K
authors.lastname: Nishio
authors.forename: Y
authors.initials: Y
authors.lastname: Takeda
authors.forename: T
authors.initials: T
authors.lastname: Ohmori
authors.forename: Y
authors.initials: Y
authors.lastname: Funayama
authors.forename: H
authors.initials: H
authors.lastname: Ogasawara
authors.forename: T
authors.initials: T
authors.lastname: Ohira
authors.forename: H
authors.initials: H
authors.lastname: Kunikane
authors.forename: Y
authors.initials: Y
authors.lastname: Terashima
authors.forename: N
authors.initials: N
authors.lastname: Saijo
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D001483:Base Sequence; D002352:Carrier Proteins / Q000032:analysis / Q000235:genetics; D004351:Drug Resistance / Q000235:genetics; D005047:Etoposide / Q000627:therapeutic use*; D005260:Female; D005434:Flow Cytometry; D015870:Gene Expression; D006801:Humans; D008562:Membrane Glycoproteins / Q000032:analysis / Q000235:genetics; D008969:Molecular Sequence Data; D009363:Neoplasm Proteins / Q000032:analysis / Q000235:genetics; D010051:Ovarian Neoplasms / Q000737:chemistry / Q000188:drug therapy* / Q000235:genetics; D013997:Time Factors; D014407:Tumor Cells, Cultured
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D002352:Carrier Proteins; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins; D005047:Etoposide